ASURAGEN, INC.
31Patents
30Active
31Granted
51Portfolio score
Filing activity: May 31, 2005 → Dec 20, 2021 · 10 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9506061B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 152 | Active |
| US7888010B2 | Methods and compositions involving microRNA | Emerging Cross-Sectional Technologies | 60 | Expired |
| US7919245B2 | Methods and compositions involving microRNA | Emerging Cross-Sectional Technologies | 56 | Active |
| US8465914B2 | Method and compositions involving microRNA | Emerging Cross-Sectional Technologies | 31 | Active |
| US8568971B2 | Methods and compositions involving microRNA | Emerging Cross-Sectional Technologies | 30 | Active |
| US7960359B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 21 | Active |
| US8173611B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 20 | Active |
| US7993831B2 | Methods of normalization in microRNA detection assays | Emerging Cross-Sectional Technologies | 19 | Active |
| US8058250B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 17 | Active |
| US8563708B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 10 | Active |
| US8409805B2 | Method of amplification of GC-rich DNA templates | Chemistry; Metallurgy | 5 | Active |
| US8735074B2 | MiRNA biomarkers of lung disease | Chemistry; Metallurgy | 5 | Active |
| US8597892B2 | MiRNA biomarkers of prostate disease | Chemistry; Metallurgy | 4 | Active |
| US8003320B2 | Methods and compositions involving MicroRNA | Emerging Cross-Sectional Technologies | 4 | Active |
| US8679757B2 | PCR methods for characterizing the 5′ untranslated region of the FMR1 and FMR2 genes | Chemistry; Metallurgy | 4 | Active |
| US8765709B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 2 | Active |
| US9051571B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 2 | Active |
| US9068219B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 2 | Active |
| US9447414B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 1 | Active |
| US9382537B2 | Methods and compositions involving miRNA and miRNA inhibitor molecules | Chemistry; Metallurgy | 1 | Active |
| US8361714B2 | Micrornas differentially expressed in cervical cancer and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9777330B2 | mPCR methods for analyzing repeat sequences | Chemistry; Metallurgy | 1 | Active |
| US9080215B2 | MicroRNAs differentially expressed in cervical cancer and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9371560B2 | Comprehensive FMR1 genotyping | Physics | 0 | Active |
| US9540645B2 | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.